MAPT and Alzheimer disease: Holtta and colleagues [5] and Herkovits and colleagues [6] reported that oligomer levels differed between AD and controls but were less effective at discriminating AD from controls than Aβ42 or t-tau and P-tau181, and they reported no statistical correlation between oAβ levels and MMSE scores.